Variant position: 369 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 419 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GTISGPEPENFGSMLELSWK GTKPIDLGN--GQTRKFLLDGDE
Mouse GTISGSDPESFGSMLELSWK GTKAIDVEQ--GQTRTFLLDG
Rat GTISGSDPESFGSMLELSWK GTKAIDVGQ--GQTRTFLLDG
Bovine GTISGPEPESFGCMLELSWK GTRAVELGN--GQTRKFLLDG
Slime mold GTISGPTEDSYGSMLELSWK GSKVVSLGTETNEERKFIQDG
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 419 Fumarylacetoacetase
350 – 350 Substrate
Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship.
Ploos van Amstel J.K.; Bergman A.J.I.W.; van Beurden E.A.C.M.; Roijers J.F.M.; Peelen T.; van den Berg I.E.T.; Poll-The B.T.; Kvittingen E.A.; Berger R.;
Hum. Genet. 97:51-59(1996)
Cited for: VARIANTS TYRSN1 ARG-193 AND VAL-369;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.